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ABSTRACT 
In India, the fidelity of electro convulsive therapy (ECT) devices is not regulated by 
any statutory body; as a result, it is conceivable that marketed devices may not meet 
the highest standards of quality. We therefore subjected 4 ECT devices, obtained 
from 4 different manufacturers, to quality testing in a biomedical engineering 
laboratory. The newest device was one month old, and the oldest device was 13 
years old. Two devices were in regular use, and two were standby instruments, We 
found that not a single device was working in accordance with the manufacturer's 
specifications. One device was not working at all; one was delivering varying intensity, 
uninterrupted current rather than constant current brief pulses (whatever the 
settings applied); one was delivering blocks of pulses the description of which was 
enormously at variance with the instrument settings; and one device, the best of 
the four, was delivering brief-pulses with small errors in each setting that cumulated 
to an error of 49.3% at a common charge setting for clinical ECT. We conclude that 
clinicians must test the fidelity of their ECT devices at the time of purchase as well 
as at frequent intervals thereafter. Finally, the fidelity of ECT devices should be 
regulated by an appropriate statutory body in India 
Key words: Electrocovulsive therapy, ETC device, medical electronics. 
METHODS 
INTRODUCTION 
Electroconvulsive therapy (ECT) is an 
important somatic treatment in psychiatry. 
ECT is delivered using a bioelectric device 
belonging to one of two broad categories: 
constant voltage, sinusoidal wave devices, or 
constant current, brief-pulse devices 
(Andrade, 1994). Electrical aspects of ECT 
have assumed great importance during recent 
years because the extent to which the 
delivered stimulus exceeds the seizure 
threshold has been shown to direcdy relate 
to both benefits and adverse effects of the 
treatment (Sackeim et al, 1987a; 1993; 2000). 
Electrical aspects of EXT have been well 
discussed elsewhere in mainstream psychiatric 
journals, emphasizing the need for clinicianf
1; 
in the field to familiarize themselves with 
the fundamentals of stimulus characteristics 
and dosing (Gordon, 1982; Railton et al, 
1987; Gangadhar and Andrade, 1989 a and * 
b; Sackeim et al, 1994; Andrade, 1994 & 
2001). 
There are two reasons why clinicians 
should confirm that the ECT device deliv-
ers stimuli in accordance with the settings 
applied: 
1. Settings that underestimate the electrical 
dose delivered expose the patient to 
an electrical charge that may be 
unnecessarily high. This may increase 
the cognitive adverse effects of ECT. 
2. Settings that overestimate the electrical 
dose delivered expose the patient to 
a possibly inadequate electrical charge. 
This may compromise the therapeutic 
effects of the treatment. In India, the 
quality of many electrical devices is 
regulated by statutory bodies such as 
the Bureau of Indian Standards (BIS); 
regrettably, ECT devices are marketed 
with no formal quality control. Any 
person with any background can design, 
manufacture, and retail an ECT device. 
K It is therefore possible that some or 
many of the ECT devices supplied to 
ECT practitioners suffer from defects 
in quality We therefore tested a 
We obtained four different ECT devices 
each supplied by a different Indian manu-
facturer. For reasons related to confidentiality, 
we are restrained from specifying either the 
manufacturer or the source of the device. 
The descriptions of the devices are as 
below : 
1 Sinusoidal wave device. This device pur-
ported to deliver sinusoidal wave stimuli 
with voltage settings of 100—140 V 
in 10 V steps, and with stimulus 
duration settings of 0.3-0.7 s in 0.1 s 
steps. As far as could be ascertained, 
the device was approximately 13 years 
old. 
2. Trolley model brief pulse device. This device 
was designed to sit on a trolley, and 
purported to deliver unidirectional, 
constant current, brief-pulse stimuli. 
There were four levels of stimulus 
control. Pulse amplitude could be set 
at 500-800 mA in 100 mA steps; pulse 
width could be set at 1.0-2.2 ms in 
0.2 ms steps; stimulus duration could 
be set at 1-4 s in 0.5 s steps; and, pulse 
frequency could be set at 60-120 Hz 
in 10 Hz steps. The device was ap-
proximately 6 years old. 
3. Briefcase model brief - pulse device. This 
device was the smallest into a briefcase, 
and purported to deliver constant 
current, brief—pulse stimuli. There 
were three levels of stimulus control. 
Pulse frequency could be set at 2-20 
Hz in irregular, 2-4 Hz steps; stimulus 
duration could be set at 0.2-2.2 s in 
0.2 steps (with a single jump from 1.4 
to 1.8ins); and, energy delivered could 
be set at 20-40 Joules in 5 Joule steps. 
The device was approximately 7 years 
old. 
4. Compact model brief-pulse device. This 
device was the smallest and the most 
compact of the four. It purported to 
deliver bi-directional, constant current, 
brief pulse stimuli. There was only 
one level of control: stimulus duration 
could be set at 0.2 s, or at 0.4-3.6s 
in 0.4 s steps, in this device, pulse 
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amplitude was fixed at 800 mA, pulse 
width was fixed at 1.5 ms, and pulse 
frequency was fixed at 125 pulses per 
second (62.5 Hz). The device was 
approximately one month old. The 
sinusoidal wave device and the brief-
case device were standby devices that 
were not in regular use. The trolley 
and compact devices were both in 
regular use at the locations from which 
they were sourced. 
None of the devices had ever been 
opened, tested, serviced, or otherwise ex-
amined during their lifetime of use. None 
of the devices had ever been considered to 
have given any cause for concern at any 
time. All four devices were studied using the 
Digital Storagescope Oscilloscope (Iwatsu 
Electric Company, Japan) in the Biomedical 
Engineering Department of the National 
Institute of Mental Health and 
Neurosciences, Bangalore. Wherever rel-
evant, the devices were tested against three 
resistances: 100 ohms, 140 ohms, and 220 
ohms. These values were selected because 
patients commonly fall within this resistance 
range (Gordon, 1982). 
RESULTS 
The Sinusoidal wave device was electri-
cally inactive. The device was opened. Several 
malfunctioning components were identified. 
Further testing was deemed inadvisable as 
the defective components could occasion 
serious damage to the sensitive parts of the 
oscilloscope.The Trolley device was found 
to deliver stimuli that were entirely independ-
ent of the stimuli set; that is, none of the 
four stimulus control knobs were working 
at any of the instrument settings. Even 
more alarmingly, far from comprising brief-
pulses, the device output was found to 
comprise an uninterrupted flow of current 
which increased in amplitude with the 
passage of time during the delivery of the 
stimulus. Thus, the instrument was actually 
delivering substantially more electrical charge 
than it was supposed to deliver. Details of 
the output of the trolley device are pre-
sented in Table I. From the table, it is 
apparent that the stimulus amplitude in-
creased progressively with increasing resist-
ance and with increasing stimulus duration; 
formal inferential statistical analysis of these 
data was not possible because of the small 
number of individual data points (n = 4) 
for each cell, corresponding to the 4 possible 
current settings on the device. The data in 
Table 1 clearly indicate that the device was 
not delivering a constant current; variation 
in actual values, depending upon resistance 
and stimulus duration, ranged from a low 
TABLE I: Current output (mA) of the 
different resistances*. 
of 80 mA to a high of 214 mA; that is, 
a difference of 167.5%. The actual currents 
were 15-40% of the values set on the 
device; that is, the instrument settings 
markedly overestimated the amplitude of 
the actual current developed by the 
instrument The briefcase device was found 
to deliver blocks of unidirectional, peaked 
trolley model current settings and with 
Stimulus 
80-100 
(9.1) 
100-120 
(11.3) 
100-140 
(13.5) 
120-160 
(15.4) 
140-160 
(17.2) 
185-214 
100 ohms 
90-109 
121.0 (8.1) 
100-127 
138.0 
118-145 
156.8 
127-163 
171.0 
136-172 
185.3 
175.0 
140 ohms 
114-128 
1 second 
128-151 
(13.8) 
142-171 
(11.8) 
157-185 
(11.4) 
171-200 
(11.8) 
(10.0) 
220 ohms 
95.0 
115.0 
2 seconds 
130.0 
3 seconds 
145.0 
4 seconds 
155.0 
5 seconds 
167.5 (17.2) 
duration 
(onset) 
(10.0) 
(10,0) 
(20.0) 
(19.1) 
(10.0) 
160-180 
196.0 
time point 
102.0 
115.8 
133.8 
147.3 
158.5 
145-181 
(15.6) 
Data are range, and mean (standard deviation) output currents for instrument settings of 
500-800 mA in 100 mA steps. 
TABLE 2 :Actual stimulus duration (ms) at different stimulus duration settings in 
the briefcase model ECT device 
Stimulus 
Duration 
0.2 
0.6 
1.0 
1.4 
2.0 
Actual 
0.46 
0.81 
1.10 
1.60 
2.56 
Error duration 
+130.00.4 
+ 35.00.8 
+ 10.01.2 
+ 14.31.8 
+ 28.02.2 
stimulus 
0.64 
0.90 
1.38 
2.10 
3.13 
% setting 
+ 60.0 
+ 12.5 
+ 15.0 
+ 16.7 
+ 42.3 
All errors were positive in direction; that is, the actual value of stimulus 
duration was higher than the value set on the instrument. 
TABLE 3 : Actual pulse block frequency (Hz) at different frequency settings in 
the briefcase model ECT device. 
Frequency  Actual  Errorsctting  frequency  % 
2 
8 
14 
20 
4.95 
5.95 
9.88 
+147.55 
- 25.610 
- 29.417 
5.65 
9.09 
9.92 
+ 13.0 
- 9.1 
- 41.6 
Continuous current; The direction of error was inconsistent; the actual value of frequency 
was higher than the value set at the lower end of the scale, and lower than the value 
set at the higher end of the scale. 
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TABLE 4 Current amplitude and voltage with different resistances in the briefcase 
model ECT device 
Resistance Current Voltage 100 ohms 1060 mA 106 v 140 
ohms 810 mA 113 V220 ohms 530 mA 117 V 
TABLE 5 Actual stimulus duration (s) at different stimulus duration settings in the compact 
model ECT device. 
Stimulus Actual Errorduration Stimulus 
Setting duration 
0.2 0.36 +90.00.4 
0.69 +72.50.8 1.06 +32.51.2 
1.42 +18.31.6 1.82 +13.820 
2.18 + 9.02.4 2.56 +6.72.8 
2.94 +5.03.2 3.30 +3.13.6 
3.65 +L4 
+ indicates error in excess of the stimulus set 
(not square) brief pulses. With different 
stimulus settings, there were 9-11 pulses per 
block, and the blocks were 96-106 ms in 
duration. Thus, each pulse was about 10 ms 
long. Stimulus durations showed a error of 
10% to 130% in the direction of actual 
duration exceeding the set duration (Table 
2). Pulse block frequency showed an error 
of 9.1% to 147.5%; the direction of error 
varied with the setting (Table 3). It can be 
observed from Table 3 that, from pulse 
block frequency settings of 10 Hz onwards, 
current was flowing almost continuously. 
This is because each block of pulses was 
about 100 ms long; thus, with a frequency 
of 9 Hz upwards, the "current on" time 
per second extended for almost the whole 
second. With 100 ms duration blocks, the 
device frequency settings of 14 Hz upwards 
are logically impossible, which must have 
been why, at the setting of 20 Hz, the 
instrument was found to deliver continuous 
pulses. Variation in resistance was found to 
result in an exactly 100% variation in 
current amplitude; in contrast, the corre-
sponding variation in voltage was just 10.4% 
(Table 4). Thus, the briefcase model was a 
constant voltage, brief-pulse device: a bio— 
medical anachronism. In view of the unusual 
voltage output of the device, the energy 
delivery Qoules) setting on the instrument 
could not be reliably tested. The compact 
device had three fixed settings: pulse width, 
pulse frequency, and pulse amplitude. The 
pulse width was fixed at 1.5 ms; this was 
found to be 1.6 ms on testing, a variation 
of 6.7%. The frequency of pulses was fixed 
at 62.5 Hz; the actual frequency was found 
to be 64.5 Hz, an error of 3.2%. The 
current amplitude was fixed at 800 mA; the 
actual current was 819 mA at 100 ohms 
resistance, 809 mA at 140 ohms, and 802 
mA at 220 ohms, an error of 0.25% to 
2.4%. The errors in stimulus duration were 
larger in range, and varied from 1.4% to 
80%; there was a progressive decrease in the 
error percentage with increase in stimulus 
duration (Table 5) .With this device, every 
measured value for every variable was 
systematically in excess of the actual setting 
A quick calculation showed that at an 
instrument setting which was set to deliver 
a charge of 120 mC (80) mA x 1.5 ms 125 
pulses per second x 0.8 s), the actual charge 
delivered was 179.2 mC; that is, a 49.3% 
excess in the delivery of charge. 
DISCUSSION 
Just as it is important to correcdy dose 
a drug during pharmacotherapy, so too is 
it necessary to correcdy dose an electrical 
stimulus during ECT (Sackeim et al 1987a 
& b, 1993, 2000). Therefore, just as the 
contents of a pill or capsule are required 
to meet the standards laid down by the 
Drug Controller of India, so too must the 
output of an ECT device meet the highest 
standards of fidelity. 
Regrettably, no regulatory body specifies 
the range of permissible error in ECT 
devices, or monitors the fidelity of such 
devices at the time of marketing or later. 
We therefore conducted a study in order to 
determine whether devices in use are faithful 
to their output settings. The sinusoidal wave 
device was an instrument that was meant 
for use in case the device in regular use 
failed. 
However, it was found to be out of 
order. 'Thus, its role as a standby device was 
defeated. Clearly, standby devices also require 
to be regularly checked. Jones (1974) reported 
the similar discovery of an electrically dead 
ECT device in active use in the UK. The 
trolley device was in regular use. Although 
it appeared to be working perfectly, none 
of the settings of pulse width, pulse 
amplitude, pulse frequency, and stimulus 
duration were actually working. Irrespective 
of the instrument settings applied, the 
instrument was found to be delivering a 
continuous current of amplitude that 
progressively increased with increase in 
(manually controlled) stimulus duration, 
rather than the brief pulses that it was 
supposed to deliver (Table 1). Such a 
stimulus can do much harm to the patient 
because the large quantum of charge that 
is delivered to the brain can occasion 
serious cognitive deficits (Sackeim et al, 
1991; Sackeim, 1992) 
Continuous local stimulation may also 
polarize tissues and cause skin burns at the 
site of electrode application (Andrade et al, 
2001). This device was therefore a very 
unsafe one from more than one point of 
view Finally, with this device, the current 
amplitude varied by a factor of 167.5%; 
thus the device was neither constant current 
nor brief-pulse, as it was supposed to be. 
The briefcase device delivered blocks of 
pulses rather than individual pulses. These 
pulses were peaked, in contrast with the 
square waves that are the expected output 
of brief-pulse devices, 'the pulses were 
massed in blocks of approximately 10 per 
block, and each pulse was approximately 10 
ms in width. These stimulus characteristics 
are wasteful in energy delivery because they 
stimulate the neurons during their refractory 
period; and, it is considered that large pulse 
widths, such as those exceeding 1 ms, may 
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be inefficient because the chronaxie of 
neurons in the mammalian nervous system 
is in the region of 0.1 -0.2 ms. (Sackeim, 
1999; Andrade, 2001). Thus, the stimulus 
waveform of this device was completely 
irrational the briefcase device, stimulus 
duration settings showed an error margin of 
up to 130% (Table 2) while stimulus fre-
quency settings showed an error margin of 
up to 147.5% (Table 3). Both these error 
values are unacceptably high. At the higher 
frequency settings on the device, the stimu-
lus output comprised almost continuous 
waves of pulses; thus, the output of this 
device was potentially as dangerous as that 
of the trolley model (see discussion above). 
Finally, the device showed a wide variation 
(100%) in the current amplitude (Table 4); 
thus, this instrument, like the trolley device, 
was neither constant current nor brief pulse, 
as it purported to be. The compact device 
was the only instrument which delivered bi-
directional brief pulses. An advantage of bi-
directional stimulation is that it avoids the 
risk of polarization of tissue at the site of 
electrode application, and hence the risk of 
skin burns during ECT (Andrade et al, 
2001). The brief pulses were square in 
shape, as claimed, and the error rate was 
a very modest 6.7% for pulse width, 3.2% 
for pulse frequency, and 2.4% (maximum) 
for current amplitude. These error values 
are generally considered acceptable within 
the limits of the mechanical components in 
electrical devices. Stimulus duration settings 
in the compact device, however, showed a 
wider margin of error; the error was as high 
as 80% at the lowest values of stimulus 
duration (Table 5). At higher values of 
stimulus duration, however, the error fell to 
values of around 10% and less. This means 
that when administering supra threshold 
ECT, as is now deemed conventional the 
proportionate error in stimulus duration 
may not be large The compact device 
delivered stimuli with values that were all 
systematically greater than those set. Thus, 
the preceding discussion notwithstanding, 
patients receiving ECT with this model will 
be over stimulated, whatever the setting 
applied. The magnitude of overstimulation 
was calculated to be 49.3% at a stimulus 
setting that was supposed to be 120 mC, 
a common charge delivered during clinical 
ECT Thus, while this device was by far the 
best of the 4 tested, it still fell short of 
the ideal. A notable point is that the pulse 
characteristics of the compact device were 
within the conventionally acceptable range 
even if they exceeded the values set. This 
means that if this device is used to titrate 
the administered dose to the individual 
patient's seizure threshold, there is no risk 
of delivery of excess electrical charge; the 
error will remain in the documentation 
alone. Risk to the patient with this device 
exists only if charge is preset using a 
formula, as suggested by certain researchers 
(Petrides and Fink, 1996; Fink, 1997; 
Gangadhar et al, 1998; Girish et al 2000); 
in such an event, the device will deliver 
more than the actual charge set, leading to 
an increased risk of cognitive adverse effects. 
Our indictment of the ECT devices studied 
herein is subject to the following limitations: 
1. We did not sample ECT devices from 
all ECT manufacturers in the country. Thus, 
it is conceivable that certain manufacturers 
retail high quality devices. However, this 
limitation does not detract from our finding 
that all four manufacturers whom we did 
address supplied instruments which, at the 
time of testing, were defective, or at least 
fell short of ideal srandards.2. We sampled 
only one device from each manufacturer. It 
is conceivable that other devices retailed by 
these manufacturers may have been better 
in quality. Unfortunately, it is logistically 
difficult if not impossible to obtain and test 
a large sample of devices from a single 
manufacturer. 3. The devices that we tested 
may have deteriorated with age. Thus, it is 
conceivable that new devices from these 
manufacturers may have been faithful to 
their settings. However, none of the devices 
had ever been considered to be defective, 
and one was practically off the shelf. 
Furthermore, many ECT devices in active 
use in ECT facilities in India are likely to 
be at least as old as certain of the devices 
we tested, if not older. Thus, our findings 
continue to be relevant to ECT practice in 
India.4. We tested only devices retailed by 
Indian manufacturers. Thus, it is conceivable 
that imported devices may be more accurate. 
However, it was the specific objective of 
our study to examine the fidelity of Indian 
devices because these are not regulated by 
statutory bodies. In conclusion. This study 
fidelity of 4 Indian ECT devices in the first 
study of its kind is India; in fact, to the 
best of our knowledge, the systematic testing 
of the fidelity of marketed ECT devices has 
never been reported anywhere else in the 
world. Although none of the devices tested 
had ever been considered to have given 
cause for concern, we found that one device 
was not working, one device was delivering 
continuous current rather than brief pulses, 
one was delivering stimuli that were far 
different from the actual settings, and one 
was delivering higher stimulus values than 
those set. The last mentioned device was 
the only truly constant current, brief-pulse 
device of the three that purported to belong 
to this class; nevertheless, the error margin 
in the last mentioned device was nearly 50% 
-at a charge of 120 mC, which is a common 
value in clinical ECT. It thus appears that, 
if our conclusions can be generalized to 
other ECT devices in the country, ECT as 
practiced in India may be, at best, 
substantially inaccurate from a dosimetric 
perspective and, at worst, shockingly unsafe. 
There is, therefore an urgent need for the 
statutory regulation of the fidelity of ECT 
devices in the country. In this context, the 
importance of a regulatory authority for 
ECT devices can be gauged from a recent 
editorial in the New England Journal of 
Medicine (Feigal et al, 2003). In the USA, 
medical devices are categorized as high-, 
medium-, or low-risk. The manufacturers of 
high-risk devices, such as ECT instruments, 
require to furnish scientific clinical evidence 
to the Food and Drug Administration that 
the devices are safe and effective in order 
to receive marketing approval. Systems that 
monitor manufacturing quality, including 
plans for corrective and preventive actions, 
are also required. Finally: ECT practitioners 
should seek the assistance of a biomedical 
engineer to test the fidelity of their ECT 
devices at the time of purchase and 
periodically thereafter; a frequency of at 
least once yearly is recommended. In at least 
some centres in the USA, hospital regulations 
require devices used on patients to be tested 
for electrical safety every 6 months for some 
devices and annually for others (Max Fink, 
2001; personal communication). It is 
necessary for practice in India to meet these 
high but attainable standards of care. 
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